专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

31. 发明申请

WO2010098625A3 PHARMACEUTICAL PREPARATION 审中-公开
标题翻译：药物制剂
公开(公告)号：WO2010098625A3
公开(公告)日：2011-01-06
申请号：PCT/KR2010001244
申请日：2010-02-26
申请人： HANALL BIOPHARMA CO LTD , KIM SUNG WUK , JUN SUNG SOO , KOO JA SEONG , KIM JIN WOOK
发明人： KIM SUNG WUK , JUN SUNG SOO , KOO JA SEONG , KIM JIN WOOK
IPC分类号： A61K9/22 , A61K31/165 , A61K31/44 , A61K47/30 , A61K47/38 , A61K47/48 , A61P3/00 , A61P9/00
CPC分类号： A61K31/165 , A61K9/209 , A61K31/44
摘要： The present invention relates to a pharmaceutical preparation comprising an immediate-release compartment containing a renin inhibitor as a pharmacologically active ingredient, and an extended-release compartment containing a dihydropyridine calcium channel blocker as a pharmacologically active ingredient. The pharmaceutical preparation of the present invention can avoid in vivo pharmacokinetic interaction between the renin inhibitor and the dihydropyridine calcium channel blocker, induces optimum pharmacological effects in accordance with the in vivo absorption performance of each of the active ingredients, and enables drugs to be released at the time period in which each of the active ingredients exhibits the pharmacological effects thereof, to thereby increase clinical effects, and can thus be valuably used in the prevention or treatment of metabolic syndrome, cardiovascular disease, and kidney disease.
摘要翻译：本发明涉及包含含有作为药理活性成分的肾素抑制剂的立即释放室和含有二氢吡啶类钙通道阻断剂作为药理活性成分的延长释放室的药物制剂。本发明的药物制剂可以避免肾素抑制剂与二氢吡啶类钙通道阻断剂之间的体内药代动力学相互作用，根据每种活性成分的体内吸收性能诱导最佳的药理作用，并使药物在每种活性成分表现出其药理作用的时间段，从而增加临床效果，因此可有效地用于预防或治疗代谢综合征，心血管疾病和肾脏疾病。

32. 发明申请

WO2010104891A1 VCO TUNING WITH TEMPERATURE COMPENSATION 审中-公开
标题翻译： VCO调谐与温度补偿
公开(公告)号：WO2010104891A1
公开(公告)日：2010-09-16
申请号：PCT/US2010/026724
申请日：2010-03-09
申请人： QUALCOMM INCORPORATED , YANG, Jeongsik , KIM, Jin, Wook , LEE, Sang-Oh
发明人： YANG, Jeongsik , KIM, Jin, Wook , LEE, Sang-Oh
IPC分类号： H03L7/099 , H03L1/02 , H03L7/10
CPC分类号： H03L7/099 , H03L1/022 , H03L7/10 , H03L7/113 , H03L2207/06
摘要： Techniques for setting a fine tuning input signal Vtune for a voltage-controlled oscillator (VCO) in a coarse tuning mode of the VCO. In an exemplary embodiment, the fine tuning input signal during coarse tuning mode is made temperature-dependent to account for possible variation of Vtune over temperature during fine tuning mode. Methods and apparatuses employing the techniques are further described.
摘要翻译：在VCO的粗调模式下为压控振荡器（VCO）设置微调输入信号Vtune的技术。在一个示例性实施例中，在微调模式期间，微调输入信号变得温度依赖于在微调模式期间Vtune随温度的可能变化。进一步描述采用这些技术的方法和装置。

33. 发明申请

WO2009127974A3 PHARMACEUTICAL FORMULATION FOR TREATING CARDIOVASCULAR DISEASE 审中-公开
标题翻译：用于治疗心血管疾病的药物制剂
公开(公告)号：WO2009127974A3
公开(公告)日：2010-03-25
申请号：PCT/IB2009006277
申请日：2009-02-23
申请人： HANALL PHARMACEUTICAL CO LTD , KIM SUNG WUK , JUN SUNG SOO , KOO JA SEONG , KIM JIN WOOK , PARK SUN WOO , JANG SEOK YOUNG , LEE SANG JU , JO YOUNG GWAN , LEE JUN YOUNG
发明人： KIM SUNG WUK , JUN SUNG SOO , KOO JA SEONG , KIM JIN WOOK , PARK SUN WOO , JANG SEOK YOUNG , LEE SANG JU , JO YOUNG GWAN , LEE JUN YOUNG
IPC分类号： A61K9/52 , A61K9/22 , A61K9/28 , A61K31/40 , A61K31/44 , A61K47/38 , A61P9/00 , A61P13/12
CPC分类号： A61K31/44 , A61K9/209
摘要： The present invention provides a pharmaceutical formulation comprising: an early release portion comprising as a pharmaceutical active ingredient a statin-based hypolipidic agent, an isomer thereof, or a pharmaceutically acceptable salt thereof; and a slow release portion comprising as a pharmaceutical active ingredient a dihydropyridine-based calcium channel blocking agent, an isomer thereof, or a pharmaceutically acceptable salt thereof. When compared with a single formulation of each of the drugs or a simple combination formulation of the drugs, the pharmaceutical formulation according to the present invention comprising an early release portion comprising a statin-based hypolipidic agent and a slow release portion comprising a dihydropyridine-based calcium channel blocking agent is pharmaceutically, scientifically, and economically very useful in preventing or treating cardiovascular disease, pulmonary heart disease, pulmonary disease, or kidney disease of patients who have a metabolic syndrome, insulin resistance, diabetes, or prediabetes. The formulation of the present invention is effective in preventing antagonistic and side effects between the drugs by making the dissolution rate of the statin-based hypolipidic agent different from that of the dihydropyridine-based calcium channel blocking agent, and in facilitating patient compliance in taking the drugs by administering the two different drugs simultaneously.
摘要翻译：本发明提供一种药物制剂，其包含：早期释放部分，其包含作为药物活性成分的基于他汀类的降血糖剂，其异构体或其药学上可接受的盐; 以及缓释部分，其包含基于二氢吡啶的钙通道阻断剂，其异构体或其药学上可接受的盐作为药物活性成分。当与药物的单一制剂或药物的简单组合制剂相比时，根据本发明的药物制剂包含早期释放部分，其包含基于他汀类的降血脂药和包含基于二氢吡啶的缓释部分钙通道阻断剂在预防或治疗具有代谢综合征，胰岛素抵抗，糖尿病或糖尿病前期的患者的心血管疾病，肺心病，肺部疾病或肾脏疾病方面在药学，科学和经济上非常有用。本发明的制剂通过使基于他汀类的降血糖剂与二氢吡啶类钙通道阻断剂的溶解速率不同而使药物的拮抗作用和副作用有效，并且为了便于患者服用药物同时服用两种不同药物。

34. 发明申请

WO2009002006A1 METHOD FOR TRANSMITTING COMPRESSED IMAGE USING MPEG-4 BIFS STREAM 审中-公开
标题翻译：使用MPEG-4 BIFS流发送压缩图像的方法
公开(公告)号：WO2009002006A1
公开(公告)日：2008-12-31
申请号：PCT/KR2008/001710
申请日：2008-03-27
申请人： NET & TV INC. , LIM, Young-Kwon , KIM, Jong-Youn , PARK, Ju-Kyung , CHOI, Eun-Hye , LEE, Yoon-Jin , KIM, Jin-Wook , HWANG, Woo-Hyun
发明人： LIM, Young-Kwon , KIM, Jong-Youn , PARK, Ju-Kyung , CHOI, Eun-Hye , LEE, Yoon-Jin , KIM, Jin-Wook , HWANG, Woo-Hyun
IPC分类号： H04N7/24
CPC分类号： H04N19/25 , H04N19/70
摘要： A compressed image transmitting method using an MPEG-4 BIFS stream is disclosed. A CompressedPixelTexture node is newly defined and added to the existing syntax of MPEG-4 BIFS. A compressed image is embedded in the BIFS stream using the CompressedPixelTexture node and transmitted, thereby reducing the frequency of use of object descriptor information and enhancing effectiveness of compressed image transmission. Accordingly, even low-capacity terminals lacking available resources such as a cellular phone, personal digital assistant and mobile terminal can be used to provide rich media services without severe performance limitation, images can be represented in BIFS contents without use of additional object descriptor information, and the transport system transmitting the BIFS contents does not have to establish an additional logical channel during multiplexing.
摘要翻译：公开了使用MPEG-4BIFS流的压缩图像发送方法。 CompressedPixelTexture节点被新定义并添加到MPEG-4 BIFS的现有语法中。使用CompressedPixelTexture节点将压缩图像嵌入到BIFS流中，并传输，从而降低了对象描述符信息的使用频率，增强了压缩图像传输的有效性。因此，即使是能够使用诸如蜂窝电话，个人数字助理和移动终端之类的可用资源的低容量终端也可以使用丰富的媒体服务而无需严格的性能限制，可以在BIFS内容中表示图像而不使用额外的对象描述符信息，并且传输BIFS内容的传送系统不必在复用期间建立附加的逻辑信道。

35. 发明申请

WO2002072082A1 THERAPEUTIC COMPOSITION FOR BROAD SPECTRUM DERMAL DISEASE 审中-公开
标题翻译：广谱光谱病的治疗组合物
公开(公告)号：WO2002072082A1
公开(公告)日：2002-09-19
申请号：PCT/KR2002/000428
申请日：2002-03-12
申请人： DOOSAN CORPORATION , PARK, Chang Seo , KIM, Jin Wook , CHOI, Jin Hee , KOH, Ui Chan
发明人： PARK, Chang Seo , KIM, Jin Wook , CHOI, Jin Hee , KOH, Ui Chan
IPC分类号： A61K31/047
CPC分类号： A61K31/047 , A61K31/133 , A61K31/66 , Y10S514/88 , Y10S514/882 , A61K2300/00
摘要： The invention relates to a therapeutic composition for broad spectrum dermal disease and in particular, to a composition comprising principal lipid components of skin, and the composition according the invention is characterized by comprising 30≈90% by weight of a carrier for applying to skin; 0.01≈5.0% by weight of Sphingolipid long-chain base; 0.001≈1.0% by weight of lysophosphatidic acid; and 1≈40% by weight of organic or inorganic additives, for the treatment and improvement of atopic dermatitis, psoriasis, acne, ichthyosis, infectious dermatitis, pruritus, erythema derived from pruritus, vulnus, chapping of skin and ulcer, etc.
摘要翻译：本发明涉及用于广谱皮肤病的治疗组合物，特别涉及包含皮肤主要脂质组分的组合物，本发明的组合物的特征在于包含30重量％的90重量％的用于施用于皮肤的载体; 0.01 APPROX 5.0％重量的鞘脂长链碱; 0.001大约1.0重量％的溶血磷脂酸; 和1大约40重量％的有机或无机添加剂，用于治疗和改善特应性皮炎，牛皮癣，痤疮，鱼鳞病，感染性皮炎，瘙痒，源自瘙痒，外阴，皮肤和溃疡等的红斑等。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式